Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Single-site Feasibility Study of Transcranial Direct Current Stimulation (tCDS), Using the Nettle Device, for the Treatment of Chronic Migraine.

NCT07214454 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT07214454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07214454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Single-site Feasibility Study of Transcranial Direct Current Stimulation (tCDS), Using the Nettle Device, for the Treatment of Chronic Migraine.
Lead sponsor
University College, London
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 1, 2026
Completion date
June 1, 2026
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic migraine headache, transcranial direct current stimulation